NCT01512524

Brief Summary

The primary objective is to assess the long-term impact of hormonal deficiency on Quality of Life (QoL) in a large group of moderate and severe Traumatic Brain Injury (TBI) patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 23, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 29, 2011

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 19, 2012

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

5.4 years

First QC Date

December 29, 2011

Last Update Submit

December 13, 2025

Conditions

Keywords

Traumatic Brain InjuryQuality of Life (QoL)hypopituitarism,GH

Outcome Measures

Primary Outcomes (1)

  • Evolution of the SF-36(Short-Form health survey)score up to 18 months post-trauma

    assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.

Secondary Outcomes (5)

  • QOLIBRI (Quality of Life after Brain Injury) measure #1

    assessed at 4 months (M4), 12 months (M12)and 18 months (M18) after brain injury.

  • Questions on Life Satisfaction-Hypopituitarism (QLS-H) measure #2

    Time frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.

  • Tests of Attentional, mnesic and executive performances #3

    assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.

  • Functional outcomes (#4):The Glasgow Outcome Scale (GOS)-Score

    assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.

  • Functional outcome #5 :the Functional Independence Measure (FIM)

    assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.

Study Arms (1)

Patients With Traumatic Brain Injury

OTHER

Study of the association between quality of life and MRI scans and endocrinology analysis (quantification of Growth Hormone) 18 months post-trauma.

Other: MRI scan and endocrinology analysis

Interventions

Endocrinology analysis including statique and dynamic exams, neuropsychologic evaluations and IRM scan.

Also known as: MRI scan, endocrinology analysis
Patients With Traumatic Brain Injury

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All subjects must be between the ages of 18-65
  • Documented moderate to severe Traumatic Brain Injury (TBI) at less than 4 months post injury.
  • Glasgow Coma Scale (GCS) equal to or greater than 12
  • Patients volunteer to participate in the study, with a written informed consent signed
  • BMI between 17 kg/m2 - 30kg/m2
  • Affiliation to a national health insurance program

You may not qualify if:

  • Glasgow Coma Scale (GCS) ≥13
  • History of TBI ≥4 months
  • Anterior hypopituitarism documented
  • History of radiotherapy
  • Liver dysfunction: total bilirubin \<20µmol/l and/or factor V\<60%)
  • Renal dysfunction: creatinine clearance \< 30 ml/mn (Cockcroft \& Gault)
  • Anyone who is currently taking or who has taken corticotherapy in the last 4 weeks before TBI
  • Pregnancy
  • Contraindications to MRI:
  • Patients who have a heart pacemaker
  • Patients who have a metallic foreign body (metal sliver) in their eye, or who have an aneurysm clip in their brain
  • Patients with severe claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

French University Hospital

Lyon, Auvergne-Rhône-Alpes, 69000, France

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Sophie Courtois, MD

    Hôpital Henry Gabrielle, Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2011

First Posted

January 19, 2012

Study Start

November 23, 2011

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

December 19, 2025

Record last verified: 2025-12

Locations